New hope for kids with chronic upset stomach: drug trial shows promise
NCT ID NCT04526119
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study tests a medicine called Z-338 in children aged 9 to 17 who have functional dyspepsia, a condition causing stomach pain and fullness after eating. The trial has two parts: first checking how the drug moves through the body, then comparing it to a placebo over 28 days to see if it eases symptoms. All participants then receive the drug for another 28 days. The goal is to find a safe and effective treatment for this common childhood digestive issue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zeria Investigative Site
Matsumoto, Nagano, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wheat sensitivity linked to fatty liver? a new study investigates
- Ancient herbal mix targets dual gut disorders in one shot
- Digestive health mystery: study seeks to uncover hidden burden of stomach pain in rural bangladesh
- New hope for chronic stomach pain: DA-9701 put to the test
- Could ginger and perilla replace acid pills for stomach trouble?
- Gut bacteria mystery: 200 patients to help uncover hidden cause of stomach pain